Welcome to CDC stacks | Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011 - 32658 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
Filetype[PDF-1.00 MB]


Details:
No Related Documents.
You May Also Like:
  1. Extensively Drug-Resistant Tuberculosis, China
    Personal Author:
    Tang, Shenjie; Zhang, Qing; Yu, Jinming; Liu, Yidian; Sha, Wei; Sun, Hua; Fan, Lin; Gu, Jin; Hao, Xiaohui; Yao, Lan; Xiao, Heping;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):558-560.
    File Type:
    Filetype[PDF - 102.65 KB]
  2. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002–2005
    Personal Author:
    Cavanaugh, J. S.; Kazennyy, B. Y.; Nguyen, M. L.; Kiryanova, E. V.; Vitek, E.; Khorosheva, T. M.; Nemtsova, E.; Cegielski, J. P.;
    Published:
    Jun 11 2012
    Source:
    Int J Tuberc Lung Dis. 16(8):1069-1074.
    Description:
    SETTING : Multidrug-resistant tuberculosis (MDR-TB) treatment facility, Orel Oblast, Russian Federation. : OBJECTIVES : To determine factors associated with poor outcome and to document status of patients after recording of TB outcomes. : DESIGN : Re...
    File Type:
    Filetype[PDF - 278.35 KB]
  3. International Research and Programs Branch annual report 2010
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination. International Research and Programs Branch.
    Published:
    10/19/2011
    Description:
    The U.S. Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination (DTBE), International Research and Programs Branch (IRPB) has worked closely with Ministries of Health (MOH) for more than 30 years, strengthening capacit...
    File Type:
    Filetype[PDF - 2.43 MB]
  4. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
    Personal Author:
    Sanchez-Padilla, Elisabeth; Dlamini, Themba; Ascorra, Alexandra; Rüsch-Gerdes, Sabine; Tefera, Zerihun Demissie; Calain, Philippe; de la Tour, Roberto; Jochims, Frauke; Richter, Elvira; Bonnet, Maryline;
    Published:
    Jan 2012
    Source:
    Emerg Infect Dis. 18(1):29-37.
    Description:
    In Africa, although emergence of multidrug-resistant (MDR) tuberculosis (TB) represents a serious threat in countries severely affected by the HIV epidemic, most countries lack drug-resistant TB data. This finding was particularly true in the Kingdom...
    File Type:
    Filetype[PDF - 294.23 KB]
  5. Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey
    Personal Author:
    Lukoye, Deus; Adatu, Francis; Musisi, Kenneth; Kasule, George William; Were, Willy; Odeke, Rosemary; Kalamya, Julius Namonyo; Awor, Ann; Date, Anand; Joloba, Moses L.;
    Published:
    Aug 01 2013
    Source:
    PLoS One. 2013; 8(8).
    Description:
    Background : Multidrug resistant and extensively drug resistant tuberculosis (TB) have become major threats to control of tuberculosis globally. The rates of anti-TB drug resistance in Uganda are not known. We conducted a national drug resistance sur...
    File Type:
    Filetype[PDF - 626.39 KB]